Reagents and consumables

Ended Awarded

Contract number
75N91020F00017
Awardee
Awarding agency
Obligated
$90,462

Award facts

Contract value 100% obligated
$90,461.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92122, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $90,461.80 order is for reagents and consumables to support the agency's genomic sequencing and analysis needs. Illumina has previously received other prime federal contracts and subcontracts from agencies like the NIH, CDC, USDA, and VA to provide a range of sequencing systems and related products and services. This order is not associated with a larger contract vehicle and does not have a set-aside designation.

Quick answers

Who was awarded contract 75N91020F00017?

75N91020F00017 was awarded to Illumina, Inc. by National Cancer Institute (National Institutes of Health) on June 29, 2020.

How much is contract 75N91020F00017 worth?

The government has obligated $90,462 on 75N91020F00017.

Is contract 75N91020F00017 an order under another contract?

Yes. 75N91020F00017 is a delivery order under HHSN268201500004I, an indefinite delivery contract.

Was contract 75N91020F00017 competed?

The extent of competition for 75N91020F00017 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award